Respiratory Disease Flashcards

1
Q

Asthma: Definiton

A

Chronic inflammatory condition associated with airway inflammation and hyper-responsiveness leading to reversible bronchial constriction.

> > childhood asthma, adult-onset asthma, exercise induced asthma, occupational asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Asthma: Epidemiology

A

8 million diagnosed with asthma in UK
5.4 million on asthma treatment
3 deaths per day due to asthma attacks
£1.1 billion on asthma each year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Asthma: Pathophysiology

A

> > exposure to irritants: cold air, exercise, smoke, pollution, allergen, medications
triggers type 1 hypersensitivity reaction mediated by IgE
T-helper 2 cells produce interleukins and cytokines
proliferation and recruitment of mast cells, eosinophils, goblet cells, neutrophils
these cells produce more inflammatory mediators&raquo_space; MAST CELLS: leukotrines, histamine, prostaglandins
goblet cells cause mucus hypersecretion

> > airflow obstruction&raquo_space; mucus, inflammation
broncho-hyperesponsiveness&raquo_space; exaggerated broncho-constriction
inflammation
airway remodelling&raquo_space; fibrotic and thickened smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Asthma: Risk Factors

A

Genetic:
» gender
» atopy: eczema, hay-fever, allergic rhinitis

Environmental:
» exposure to allergens
» smoking
» exposure to animals
» socio-economic status

Other:
» stress
» medication
» diet and nutrition
» prenatal smoking
» recurrent respiratory infections
» occupation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Asthma: Symptoms

A

Wheeze
Chest tightness
Cough
Dysponea
Decreased exercise tolerance

All symptoms typically diurnal&raquo_space; symptoms worse at night

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Asthma: Signs

A

Between sthma exacerbations, clinical examination may be normal.

Tachypnoea
Use of accessory muscles
Polyphonic wheeze&raquo_space; lots of different pitched noises
Hyperinflated chest
Hyper-resonant percussion note

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Asthma: Diagnosis

A

History + examination + investigation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Asthma: Investigations

A

Spirometry-
» offered to all over 5 years
» blow into device as hard, fast, long as patient can
» FEV1/FEV ratio less than 70% = confirms airway obstruction
» then, do Bronchodilator Reversibility (BDR)&raquo_space; give bronchodilator and do spirometry again
» if increase of over 12% in FEV1 and 200ml increase in FEV1 = positive result = diagnosable asthma

Fractional exhaled nitrix oxide testing (FeNO)-
» offered to all adults
» NO levels high in asthma patients due to eosinophilic inflammation
» a reading of over 40 part per billion (ppb) = positive
» if FeNO is positive = suggestive of asthma

Peak Expiratory Flow (PEF)-
» offered to all adults
» blow into device as hard and as fast as patient can
» peak flow diary 2x daily for 2-4 weeks
» over 20% variability between highest and lowest result = suggestive and diagnostic for asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Asthma: Extra Investigations

A

Respiratory exam: confirm symptoms and signs
CVS exam: rule out other causes of symptoms
ENT exam: polyps
X-ray
FBC: inflammatory cells
Sputum sample

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Asthma: Investigations for Children

A

Children under 5 years-
» can’t perform objective testing
» use clinical judgement, signs and symptoms, and any positive results

Spirometery: 5-16yrs = FEV1 of 12% or more is positive
FeNO: 5-16yrs = result of 35ppb is positive
PEF: 20% variability is positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Asthma: Management for Adults

A

For adults 17+
For young adults 5-16&raquo_space; same but paediatric dose of ICS
GIVE SPACER FOR INHALERS

STEP 1: Prescribe an inhaled short-acting β2 agonist (SABA)as reliever therapy&raquo_space; salbutamol, salamol, aeromir
STEP 2: Prescribe an inhaled corticosteroid (ICS) as preventer therapy&raquo_space; clenil
STEP 3: Leukotriene receptor antagonists (LTRAs) orally as first-line add-on treatment to low dose ICS in adults&raquo_space; montelukast
» recommended 4-8week trial period before LABA
STEP 4: Offer a long-acting beta-2 agonist (LABA) in combination with the ICS&raquo_space; never LABA without ICS as risk of death
» no need to continue LTRA if not useful&raquo_space; use clinical judgement
STEP 5: If still uncontrolled start MART treatment plan: fast onset LABA and ICS&raquo_space; symbicort and fostair
» MART: maintenance and reliever therapy
STEP 6: MART plan: fast onset LABA with high dose ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Asthma: Stepping Up and Down

A

Asthma action plan&raquo_space; (1) everyday asthma plan (2) when I feel worse (3) In an asthma attack
Review asthma plan yearly
Review patient after 6 months of changing treatment

If reliever inhaler needed more than 3 times per week&raquo_space; poor management STEP UP NEEDED

USE ASTHMA CONTROL TEST
NICE guidline on complete control over asthma:
» no daytime symptoms due to asthma
» no limitations on daily activities due to asthma
» no night waking due to asthma
» no reliever needed

If complete control for minimum 3 months, consider STEP DOWN treatment
» aim for lowest step
» when reducing ICS, drop 25-50% every 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Asthma: Management for Children

A

For children under 5 years

STEP 1: offer SABA for suspected asthma as reliever
STEP 2: consider 8-week trial for paediatric dose of ICS
STEP 3: after 8-weeks stop ICS treatment monitor
» if symptoms DON’T resolve, review diagnosis
» if symptoms DO resolve, but symptoms recur within 4 weeks of stopping, restart paediatric-dose ICS treatment for maintenance therapy
» if symptoms DO resolve, but symptoms recur after 4 weeks of stopping, repeat 4 week ICS trial period

STEP 4: addition of LTRA that are authorised for children
STEP 5: REFER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Acute Asthma: Definition

A

Acute severe asthma is an acute exacerbation of asthma that does not respond to standard treatments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acute Asthma: Severity

A

Moderate-
» increasing symptoms
» PEFR > 50% of predicted or best
» no features of severe/life-threatening asthma

Severe-
» PEFR 33-50% of predicted or best
» heart rate > 110/min
» respiratory rate > 25/min
» unable to complete sentences in one breath.
» accessory muscle use

Life-threatening-
» PEFR < 33% of predicted or best
» Oxygen saturation < 92% or cyanosis
» normal PaCO2
» altered conciousness/confusion
» exhaustion
» poor respiratory effort
» hypotension
» silent chest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acute Asthma: Risk Factors

A

Previous ITU admissions
Far along treatment steps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Acute Asthma: Investigations

A

PEFR: to help classify severity
Chest X-ray: exclude pneumothorax or consolidation
FBC : find cause
CRP: C-reactive protein is produced by the liver&raquo_space; indicates inflammation in the body
ABG: check PaO2 and PaCO2
» if PaCO2 is normal = life threatening
» if PaCO2 is raised = near fatal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Acute Asthma: Management

A

IMMEDIATELY ADMIT
» oxygen, SABA, steroids

> > ABCDE assessment
oxygen to maintain saturations of 94-98%
SABA: 4 puffs initially, 2 puff every 2 minutes, upto 10 puffs OR nebulised SABA
steroids: oral prednisolone or IV hydrocortisone

> > nebulised ipratropium bromide&raquo_space; SAMA
consider IV magnesium sulphate if patient not responding&raquo_space; magnesium is CCB and causes bronchiodilation

ITU if no improvement
May require intubation and mechanical ventilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Acute Asthma: Follow Up

A

Notify primary care within 24 hours
Follow up within 2 days of discharge
Check obs and peak flow
Address preventable contributors&raquo_space; vaccines, smoking, mould
Ensure written plan
Set up regular therapy, as needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Smoking Cessation

A

ENCOURAGE ALL PATIENTS TO STOP SMOKING
» stopping smoking can prevent 15 types of cancers
» smokers require higher doses of ICS for prevention

Pharmacological treatments-
» nicotine replacement therapies: nicotine patches, lozenge, chewing gum&raquo_space; CANNOT CONTINUE SMOKING
» varenicline (champix): blocks nicotine receptors in brain, 12 week course, over 18 and not pregnant or breast feeding&raquo_space; CAN CONTINUE SMOKING
» bupropion

Non-pharmacological treatments-
» vaping
» community support
» therapy and counselling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Acute Bronchitis: Definition

A

Inflammation of the bronchioles and mucus secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Acute Bronchitis: Pathophysiology

A

Commonly viral: influenza, rhinovirus, RSV
Sometimes bacterial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Acute Bronchitis: Risk Factors

A

Smoking
Damp or dusty environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Acute Bronchitis: Symptoms

A

Healthy person with cough&raquo_space; lasts 7-10 days but can persist upto 3 weeks
Pleuritic or retrosternal pain
Fever
Headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Acute Bronchitis: Signs
Often no clinical signs >> coarse crepitations, wheeze
26
Acute Bronchitis: Management
Resolved by itself- >> resolution typically 3 weeks >> analgesia, fluids, smoking cessation, rest >> typically no antibiotics because usually caused by viral infection >> consider delayed antibiotic with advice Immediate antibiotic if- >> over 80 with ONE of: hospitilisation within past year, heart failure, oral steroids, diabetic >> over 65 with TWO of: hospitilisation within past year, heart failure, oral steroids, diabetic >> prescribe amoxicillin 500mg, 3x per day
27
Influenza: Definition
Influenza or 'flu' is a single-stranded RNA virus causing URTI Typically self-limiting >> resolves by itself without medical intervention >> can cause mortality in patients with co-morbidities
28
Influenza: Epidemiology
Three serotypes: A, B, and C >> A and B respnsible for epidemic respiratory infections >> seasonal influenza caused by mix of A and B
29
Influenza: Pathophysiology
Viral: highly contagious, and transmitted by respiratory secretions
30
Influenza: Symptoms and Signs
Incubation period is typically 1–4 days Patients can remain infectious for 7–21 days Fever ≥ 37.8°C Nonproductive cough Myalgia Headache Malaise Sore throat Rhinitis Infants and children: fatigue, irritability, diarrhoea, vomitting
31
Influenza: Management
Self-limiting disease Fever, myalgia, headache >> paracetamol, ibuprofen Fluids Rest Avoid smoking Throat loszenges Saline nose drops Decongestants
32
Influenza: Complications
Acute bronchitis Influenza related pneumonia Exacerbations of asthma, COPD, HF
33
Influenza: Vaccinations
Influenza vaccine is an inactivated vaccine tailored each year according to recent outbreaks. Free flu vaccine eligability- >> pregnant >> front-line healthcare worker >> long-term care home residant >> carer >> patients with chronic conditions >> age over 65 >> very overweight Children- >> 6-12 months should have flu jab >> 2-17 years have yearly nasal spray vaccine
34
Pneumonia: Definition
Lung tissue infection that causes the air sacs in the lungs to fill with fluid, inflammatory cells, and microorganism. >> leads to consolidation of the lung tissue >> impairs gas exchange and can lead to hypoxia
35
Pneumonia: Types
Types of pneumonia: >> Community-acquired pneumonia (CAP) >> Hospital-acquired pneumonia (HAP) >> Pneumonia in immunocompromised individuals
36
Pneumonia: Aetiology
Pneumonia can be caused by viruses, bacteria, and fungi >> most common: Strep pneumonia >> common: Staph aureus, Mycoplasma pneumoniae, Haemophilus influenzae >> uncommon: klebsiella pneumonia, strep pyogenes, pseudomonas, aeruginosa, Coxiella burnetti, Chlamydia psittaci, Actinomyces Israeli
37
Pneumonia: Pathophysiology
>> Inflammation of lungs due to infection >> fluid and blood cell leak >> consolidated tissue >> impaired gas exchange >> reduced ventilation
38
Pneumonia: Risk Factors
Age >> infants and the elderly Smoking Alcohol excess >> organ damage, aspiration pneumonia Preceding viral infections >> flu Bronchial obstruction >> COPD Bronchiectasis >> permanent widening and thickening of lung airways Immunosuppression >> AIDS, chemotherapy Hospitalisation Underlying predisposing disease >> Diabetes, CVD
39
Pneumonia: Symptoms
Fever Sweating Shivers Malaise Rigors Cough Purulent sputum Pleuritic chest pain >> chest pain on inspiration Haemoptysis
40
Pneumonia: Signs
Tachypnoea Tachycardia Hypotension Cyanosis Dullness to percussion over the consolidated area Increased vocal resonance/ tactile vocal fremitus over the consolidated area Pleural rub Lower lobe crackles
41
Pneumonia: Investigations
Sputum culture CXR >> consolidation and fluid FBC U+E >> for AKI LFTs
42
Pneumonia: Management
Oxygen if low saturations IV fluids if dehydrated Analgesia for myalgia or chest pain Escalate for respiratory support Oral antibiotics >> amoxicillin 500mg, 3x per day for 5 days IV antibiotics for those admitted with more severe pneumonia >> co-amoxiclav and clarithromycin >> check for penicillin allergies Antibiotics should be tailored to antimicrobial sensitivities Repeat CHX after 6-8 weeks >> screen for lung cancer
43
Streptococcus Pneumonia: Definition
Infection of lungs caused by streptococcus pneumoniae bacteria Homogeneous consolidation of one or more lobes or segments >> also called pneumococcal pneumonia, community acquired pneumonia
44
Streptococcus Pneumonia: Epidemiology
All ages >> specifically early and middle adult life
45
Streptococcus Pneumonia: Pathophysiology
Droplet spread Streptoccocus pneumoniae >> inflammation of lungs due to infection >> fluid and blood cell leak >> consolidated tissue >> impaired gas exchange >> reduced ventilation
46
Streptococcus Pneumonia: Symptoms
Cough Purulent sputum Fever Aches and pains Vomiting Anorexia Pleuritic chest pain Dyspnoea
47
Streptococcus Pneumonia: Investigations
FOR ALL PATIENTS WITH PNEUMONIA- Chest X-ray Sputum culture >> only in secondary care and if urgent FBC >> WBC U&E >> urea LFTs >> albumin
48
Streptococcus Pneumonia: Management
Penicillin or cephalosporin
49
Streptococcus Pneumonia: CURB-65 Score
Classified using the CURB-65 score to determine severity and guide management One point is awarded for each of the following- >> confusion >> urea > 7mmol/L >> respiratory rate > 30 breaths/min >> blood pressure < 90 systolic and/or < 60mmHg diastolic >> 65 years or older A CURB-65 score of: >> 0-1 requires home treatment >> 2 should consider hospital admission >> 3-5 admit to hospital and consider ITU referral
50
Streptococcus Pneumonia: Complications
Exudate Pleural effusion Lung abscess Bacteraemia >> sepsis, endocarditis, meningitis, arthiritis, otitis media
51
Atypical Pneumonia: Definition
Less common Not detectable on gram staining
52
Atypical Pneumonia: Epidemiology
Commonly affect healthier people Typically less severe >> more severe in immuno-compromised
53
Atypical Pneumonia: Pathophysiology
Organisms that cause atypical pneumonia- Mycoplasma pneumoniae Chlamydophila pneumoniae Legionella pneumophila
54
Atypical Pneumonia: Mycoplasma pneumonia
Caused by: Mycoplasma pneumoniae Most common cause of atypical pneumonia Epidemiology- Peak rate in autumn/early winter Epidemic every 3-4 years Risk Factors- Common in barracks and institutions Children and young adults at higher risk Symptoms- Present insidiously with flu-like symptoms >> progresses to pnuemonia symptoms >> PERSISTANT DRY COUGH Investigations- CXR or CT consolidation >> homogenous dense lobar, patchy, nodular Treatment- erythromycin/clarithromycin or tetracycline
55
Atypical Pneumonia: Legionella pneumonia
Caused by: Legionella pneumophila Mortality 15% >> most commonly due to resp. failure Epidemiology- Typically present in water sources >> can spread via air conditioning Symptoms- Previously healthy paitent >> air conditions Present with: cough, chills, temp, myalgia, nausea, vomitting, diarrhoea, confusion PLEURITIC CHEST PAIN AND COUGH Investigations- CXR, blood culture, Legionella serology, urine antigen Treatment- Erythromycin 14-21 days, oxygen, IV fluids >> 1st line Rifampicin BD by mouth or IV >> severly ill patients Complications- Less severe: confusion, hepatitis, renal impairement More severe: hyponatreamia, lung abscess, empyema, hypotension
56
Atypical Pneumonia: Chlamydophila pneumonia
Caused by: Chlamydophila pneumoniae Mortality 15% >> most commonly due to resp. failure Epidemiology- Most common chlamydial infection Spread via droplets Biphasic illness Symptoms- Present with: pharyngitis, hoarsness, otitis media >> followed by pneumonia PRODUCTIVE WATERY COUGH Investigations- CXR, chlamydial PCR, nasopharyngeal swab, sputum or pleural fluid sample Treatment- Azithromycin >> 1st line Tetracyclin >> 2nd line
57
Atypical Pneumonia: Investigations
CXR, blood cultures, serology, chlamydial PCR Mycoplasma pneumoniae- ground-glass shadowing Chlamydophila pneumoniae- consolidation Legionella pneumophila- patchy consolidation
58
Atypical Pneumonia: Management
Responds to antibiotics: macrolides (azithromycin and clarithromycin) and doxycycline
59
Hospital Acquired Pneumonia: Definition
Pneumonia acquired less than 48 hours after admission to hospital
60
Hospital Acquired Pneumonia: Epidemiology
More likely than pneumonia acquired at home
61
Hospital Acquired Pneumonia: Pathophysiology
Most common causative organisms- Pseudomonas aeruginoa Staphylococcal aureus Enterobacteriaceae >> Klebsiella, E.coli, Enterobacter
62
Hospital Acquired Pneumonia: Staph. Aureus
Epidemiology: 2% of pneumonia in UK Typically secondary to influenza infection Pathophysiology: Widespread infection with abscess formation Seen in immunocompromised patients Risk Factors: Intravenous drug abusers >> puncture sites introduce infections Treatment: Flucloxacillin >> 1st line Erythromycin >> if allergic
63
Hospital Acquired Pneumonia: Klebsiella Pneumonia
Epidemiology: Uncommon High mortality 20-50% Pathophysiology: Massive consolidation and excavation of lobes >> ususally upper lobes Presentation: High fever, rigors, pleuritic pain Sputum is purulent, haemoptysis Risk Factors: Associated with alcoholism, diabetes, COPD, elderly Treatment: Cefuroxime
64
Hospital Acquired Pneumonia: Pseudomonas Pneumonia
Risk Factors: Common pathogen in bronchiectasis, CF, hospital acquired infections (ITU, post-surgery) Diagnosis: Sputum culture Treatment: Antipseudonomal penicillin
65
Pneumocystic Jirovecii Pneumonia: Definition
Pneumocystis carinii pneumonia (PCP) Pneumocystic jirovecii pneumonia (PJP) Pnemonia in the immunosupressed
66
Pneumocystic Jirovecii Pneumonia: Pathophysiology
Caused by fungus: pneumocystis jirovecii
67
Pneumocystic Jirovecii Pneumonia: Symptoms
Dry cough Exertional dyspnoea Hypoxaemia Fever Bilateral crepitations
68
Pneumocystic Jirovecii Pneumonia: Investigations
CXR >> normal OR bilateral peripheral interstitial shadowing Visulisation of organisam in sputum Bronchoalveolar lavage (BAL) >> tube with fluid put down and brough back up
69
Pneumocystic Jirovecii Pneumonia: Treatment
High dose co-trimoxazole, pentamidine Steroid if hypoxaemia Prophylaxis if CD4 count <200 (normal CD4 500-1200)
70
Acute Bronchiolitis: Definition
LRTI of bronchioles causing inflamamtion in small bronchi and bronchioles
71
Acute Bronchiolitis: Epidemiology
Typically seen in infants and young children <2 years During autumn and winter
72
Acute Bronchiolitis: Pathophysiology
Viruses infect bronchiolar epithelial cells >> inflammation in small bronchi and bronchioles Common caused by respiratory syncytial virus (RSV) >> commonly causes bronchiolitis in infant and pneumonia in adults >> other causes: rhinovirus, parainfluenza, influenza, COVID, adenovirus
73
Acute Bronchiolitis: Symptoms and Signs
Fever Nasal congestion Rhinorrhoea Persistant cough Dyspnoea >> difficulty breathing Wheeze Intercostal rescession Peripheral cynosis Typically begins with URTI, progresses to LRTI
74
Acute Bronchiolitis: Diagnosis
Clinical diagnosis Respiratory exam CXR or virology >> only if other concerns
75
Acute Bronchiolitis: Management
Self-limiting >> typically resolves within 1-2 weeks Supportive care- >> analgesia, hydration, nutrition Indications for hospitalisation- >> toxic appearacnce, central cyanosis, lethargy, dehydration, severe resp. distress, hypoxia A&E management- >> Inhaled bronchodilators, IV fluids, oxygen, nasal suction, intubation
76
Croup: Definiton
URTI also known as acute laryngotracheobronchitis
77
Croup: Epidemiology
Affects children between 6 months - 6 years >> peak incidence at 2 years More often in autumn and winter
78
Croup: Pathophysiology
Most common cause: human parainfluenza virus 1 Infection and inflammation of laryngeal mucosa >> laryngeal oedeam, thick tenacious mucus >> obstructed trachea and airways Onset slower than acute epiglottitis
79
Croup: Symptoms and Signs
Prodromal phase of coryzal symptoms Harsh barking cough Hoarse voice or cry Inspiratory stridor
80
Croup: Modified Westley Score
Modified Westley scoring: >> chest wall retractions >> stridor >> cyanosis >> level of consiousness >> air entry 0–2: Mild croup 3–5: Moderate croup 6–11: Severe croup 12–17: Impending respiratory failure
81
Croup: Investigations
Clinical diagnosis Use modified Westley score for severity
82
Croup: Treatment
Largely self-limiting Supportive care- >> analgesia, hydration, nutrition, rested, oxygen, fever management Severe care- >> dexamethasone 150mcg orally (steroid) >> nebulised budesonide 2mg (steroid) >> nebulsied adrenaline 5mg
83
Pertussis: Definition
Highly contagious bacterial infection of the lungs and airways
84
Pertussis: Epidemiology
Under 6 months >> increased mortality
85
Pertussis: Pathophysiology
Bordetella pertussis - gram negative bacteria
86
Pertussis: Symptoms and Signs
Cough paroxysm >> coughing fit Long-term hacking cough Whooping cough Post-cough vomitting
87
Pertussis: Investigations
Nasopharyngeal swab >> idealy under 2 weeks Oral fluid swabs Serology-anti-pertussis toxin IgG >> over 2 weeks
88
Pertussis: Management
Vaccine- >> for 16-31 weeks pregnant >> childhood scheduled vaccines Hospital admission if under 6 months, or severly unwell Macrolides to reduce infective peroid >> clarithromycin, azithromycin Oxygen if cyanosis
89
Acute Epiglotittis: Definition
Inflammation and swelling of the epiglottis MEDICAL EMERGENCY
90
Acute Epiglotittis: Epidemiology
Rare Children 2-5 years Adults 40-50 years
91
Acute Epiglotittis: Pathophysiology
Commonly caused by: haemophilus influenzae, streptoccocus pneumoniae Localised infection of supraglottic larynx
92
Acute Epiglotittis: Symptoms and Signs
Muffled voice (hot potatoe voice) Hoarse cry Stridor Drooling Fever Painful/inability to swallow Tripod position Fever No cough
93
Acute Epiglotittis: Investigation
DO NOT LOOK INSIDE MOUTH >> may exacerbate
94
Acute Epiglotittis: Management
Emergency referal Airway management Manage fever Refer laryngoscopy >> gold standard IV antibiotics
95
Tuberculosis: Definition
Tuberculosis is an infection with the Mycobacterium tuberculosis bacterium Lung is the major seat of infection and the usual portal through which infection reaches other organs >> can infect multiple other organ systems Active TB: symptomatic, progressive, and contagious Latent TB: persistent immune response to prior acquired antigens, forms tuberculoma >> asymptomatic and not contagious
96
Tuberculosis: Epidemiology
High incidence in Africa and Asia Multi drug resistant TB is a public health crisis >> notifiable disease in UK 2nd leading infectious killer TB is present in all countries and age groups but is curable and preventable
97
Tuberculosis: Pathophysiology
Mycobacterium tuberculosis: aerobic, slow growing bacteria >> acid fast bacilli: resistant to acid staining Spread via droplets >> Bacteria enters respiratory system >> 70% people will clear infection Others may become infected and supress the disease and so show no signs or symptoms >> latent TB >> latent TB: granulomas will form around the bacteria to prevent immune system from attacking it >> TB bacteria remains in body, inactive Others develop disease immedietly >> active TB
98
Tuberculosis: Types
Active TB: patient is symptomatic or there is progression of the disease in the lung or other organs >> most common presentation Miliary TB: a severe and disseminated form of TB, where the bacteria spread through the bloodstream, affecting multiple organs throughout the body Latent TB: the immune system contains the infection, with alveolar macrophages playing a major role in the formation of granulomas which contain the bacteria >> asymptomatic and not contagious Reactive TB: if latent TB becomes reactive >> 5-10% of people with latent TB will experience
99
Tuberculosis: Risk Factors
Close contact of TB patient Homeless patients or living in close quarters Alcohol and other drug misuse Immunocompromised patients >> HIV Elderly patients
100
Tuberculosis: Common Symptoms and Signs
Systemic- Night sweats Fevers Weight loss Malaise Lymphadenopathy Respiratory- Chronic productive cough Haemoptysis Shortness of breath Collapse, pain, or pleural effusion >> dull to precussion
101
Tuberculosis: Other Symptoms and Signs
Heart and pericardium: pain, arrhythmias, cardiac failure, pericarditis Intestine: malabsorption, diarrhoea, obstruction GI tract: haematuria, renal failure, epididymitis, salpingitis, infertility Skin: erythema nodosum, lupus vulgaris Eyes: iritis, choroiditis, keratoconjunctivitis Bones/Joints: arthritis, osteomyelitis Lymphatics: lymphadenopathy, cold abscesses, sinuses Brain: tuberculoma, meningitis
102
Tuberculosis: Active TB Investigations
If active TB suspected- Chest X-ray Sputum culture x3 >> for acid fast bacilli smear, mycobacterial culture, nucleic acid amplification testing (NAAT) >> samples for microscopy, culture and sensitivity testing (MCS) >> stained with Ziehl-Neelsen or Auramine staining >> at least one sample from early morning Additional testing depending on suspected site of infection
103
Tuberculosis: Latent TB Investigations
If inactive TB is suspected- Mantoux test >> injecting 0.1mL of liquid containing tuberculin purified protein derivative(PPD) into top layers of forearm skin >> check 48-72 hours after injection >> positive if ≥5 mm skin induration Interferon-gamma release assay test >> a blood test which detects the white blood cell response to TB antigens >> faster, less false positives If Mantoux or IGRA tests positive, should exclude active TB >> history >> physical examination >> chest x-ray: granulmoas/nodules >> Any other abnormalities: send for sputum test
104
Tuberculosis: Ative TB Treatment
Initial 2 months of- >> rifampicin (colours urine, sweat, and tears red/brown 4 hours after dose)(not allowed contraception for 8 weeks after Rifampicin) >> isoniazid with pyradoxine (vit B6 to mitigate common neuro side effects) >> pyrazinamide >> ethambutol Followed by 4 month of- >> rifampicin >> isoniazid with pyradoxine (vit B6) TREATMENT STARTED IF SUSPECTED OF ACTIVE TB without waiting for culture results, then modified Compliance is CRUCIAL >> risk of multi-drug resistant TB Modify treatment regimen according to drug susceptability testing Longer courses of antibiotics in TB meningitis, pericardial and spinal TB >> affecting CNS Multidrug-resistant TB often requires 18-24 months of treatment with at least six drugs Contact tracing, care co-ordination via TB MDT, monitor adherence, mask until >2 weeks of treatment
105
Tuberculosis: Latent TB Treatment
For 3 months- >> rifampicin >> isoniazid with pyradoxine (vit B6) OR For 6 months- >> isoniazid with pyradoxine (vit B6)
106
Tuberculosis: Prevention
BCG vaccination is a live attenuated vaccine that is given to protect against TB It is not a routine part of the UK's childhood vaccination schedule but is given to babies (or children up to 16) at higher risk
107
Tuberculosis: Complications
Pleural effusion Empyema >> collection of pus in pleural cavity Pneumothorax >> collapsed lung, air leaking from lung within pleural cavity Laryngitis Enteritis >> inflammation of small intestine Mycetoma Cor pulmonale Death
108
Pleural Effusion: Definition
Accumulation of excess fluid within pleural cavity >> impede respiration as the lung cannot expand fully X-ray >> white=fluid
109
Pleural Effusion: Pathophysiology
Causes classified into trasudative or exudative- Transudative: where changes in oncotic and hydrostatic pressure cause fluid to leak from the vasculature >> typically watery, transparent >> causes: HF, renal failure, liver failure, PE >> lower pleural proteins Exudative: where inflammation leads to increased microvascular permeability and drainage of pleural fluid may be impaired >> contains materials, pus >> causes: infection, cancer, autoimmune, drugs, PE >> can have right-sided or left-sided secondary causes >> higher pleural proteins
110
Pleural Effusion: Light's criteria
Used to differentiate between transudative and exudative plural effusion If any criteria met, then exudative: >> ratio of pleural to serum protein is greater than 0.5 >> ratio of pleural to serum LDH is greater than 0.6 >> pleural fluid LDH is greater than ⅔ of the upper limit of normal serum value
111
Pleural Effusion: Symptoms
Shortness of breath Reduced exercise tolerance Dry cough Pleuritic chest pain >> sharp, stabbing, worsens on breathing in and out, holding breath helps
112
Pleural Effusion: Signs
Reduced chest expansion on the affected side Dull on percussion over the effusion Reduced or absent breath sounds over the effusion Loss of vocal resonance over the effusion Tracheal deviation away from the effusion Respiratory distress >> use of accessory muscles HF: peripheral oedema, raised JVP
113
Pleural Effusion: Differential Diagnosis
Haemothorax: >> a collection of blood in pleural cavity >> usually secondary to trauma >> can occur spontaneously >> due to malignancy or vascular rupture Chylothorax: >> chylous fluid in the pleural cavity >> due to lymphatic duct injury or obstruction >> common causes include iatrogenic injury during thoracic surgery, traumatic injury or lymphoma Empyema: >> a collection of pus in the pleural cavity >> usually develop as a complication of pneumonia Mesothelioma: >> tumour of the pleura >> strongly associated with asbestos exposure.
114
Pleural Effusion: Investigations
Respiratory exam: >> pleural tap, vocal resosonance, chest sounds Chest X-ray: first line >> blunting of costophrenic angle or white out of the lung FBC
115
Pleural Effusion: Management
Thoracocentesis: >> pleural tap or pleural aspiration >> is a minimally invasive medical procedure that removes fluid or air from the pleural space >> sit patient upright >> leaning on pillow >> insert needle and drain fluid out above rib to avoid neurovascular bundle for diagnosis and symptom relief Management and treatment depends on size, symptom and cause